Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

343 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth.
Bruchard M, Mignot G, Derangère V, Chalmin F, Chevriaux A, Végran F, Boireau W, Simon B, Ryffel B, Connat JL, Kanellopoulos J, Martin F, Rébé C, Apetoh L, Ghiringhelli F. Bruchard M, et al. Among authors: ghiringhelli f. Nat Med. 2013 Jan;19(1):57-64. doi: 10.1038/nm.2999. Epub 2012 Dec 2. Nat Med. 2013. PMID: 23202296
Freshly isolated bone marrow cells induce death of various carcinoma cell lines.
Larmonier N, Ghiringhelli F, Larmonier CB, Moutet M, Fromentin A, Baulot E, Solary E, Bonnotte B, Martin F. Larmonier N, et al. Among authors: ghiringhelli f. Int J Cancer. 2003 Dec 10;107(5):747-56. doi: 10.1002/ijc.11463. Int J Cancer. 2003. PMID: 14566824
CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative.
Ghiringhelli F, Larmonier N, Schmitt E, Parcellier A, Cathelin D, Garrido C, Chauffert B, Solary E, Bonnotte B, Martin F. Ghiringhelli F, et al. Eur J Immunol. 2004 Feb;34(2):336-44. doi: 10.1002/eji.200324181. Eur J Immunol. 2004. PMID: 14768038
Increased immunogenicity of colon cancer cells by selective depletion of cytochrome C.
Schmitt E, Parcellier A, Ghiringhelli F, Casares N, Gurbuxani S, Droin N, Hamai A, Pequignot M, Hammann A, Moutet M, Fromentin A, Kroemer G, Solary E, Garrido C. Schmitt E, et al. Among authors: ghiringhelli f. Cancer Res. 2004 Apr 15;64(8):2705-11. doi: 10.1158/0008-5472.can-03-2475. Cancer Res. 2004. PMID: 15087383
Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation.
Ghiringhelli F, Puig PE, Roux S, Parcellier A, Schmitt E, Solary E, Kroemer G, Martin F, Chauffert B, Zitvogel L. Ghiringhelli F, et al. J Exp Med. 2005 Oct 3;202(7):919-29. doi: 10.1084/jem.20050463. Epub 2005 Sep 26. J Exp Med. 2005. PMID: 16186184 Free PMC article.
CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
Ghiringhelli F, Ménard C, Terme M, Flament C, Taieb J, Chaput N, Puig PE, Novault S, Escudier B, Vivier E, Lecesne A, Robert C, Blay JY, Bernard J, Caillat-Zucman S, Freitas A, Tursz T, Wagner-Ballon O, Capron C, Vainchencker W, Martin F, Zitvogel L. Ghiringhelli F, et al. J Exp Med. 2005 Oct 17;202(8):1075-85. doi: 10.1084/jem.20051511. J Exp Med. 2005. PMID: 16230475 Free PMC article.
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death.
Casares N, Pequignot MO, Tesniere A, Ghiringhelli F, Roux S, Chaput N, Schmitt E, Hamai A, Hervas-Stubbs S, Obeid M, Coutant F, Métivier D, Pichard E, Aucouturier P, Pierron G, Garrido C, Zitvogel L, Kroemer G. Casares N, et al. Among authors: ghiringhelli f. J Exp Med. 2005 Dec 19;202(12):1691-701. doi: 10.1084/jem.20050915. J Exp Med. 2005. PMID: 16365148 Free PMC article.
A novel dendritic cell subset involved in tumor immunosurveillance.
Taieb J, Chaput N, Ménard C, Apetoh L, Ullrich E, Bonmort M, Péquignot M, Casares N, Terme M, Flament C, Opolon P, Lecluse Y, Métivier D, Tomasello E, Vivier E, Ghiringhelli F, Martin F, Klatzmann D, Poynard T, Tursz T, Raposo G, Yagita H, Ryffel B, Kroemer G, Zitvogel L. Taieb J, et al. Among authors: ghiringhelli f. Nat Med. 2006 Feb;12(2):214-9. doi: 10.1038/nm1356. Epub 2006 Jan 29. Nat Med. 2006. PMID: 16444265
Chemoimmunotherapy of tumors: cyclophosphamide synergizes with exosome based vaccines.
Taieb J, Chaput N, Schartz N, Roux S, Novault S, Ménard C, Ghiringhelli F, Terme M, Carpentier AF, Darrasse-Jèze G, Lemonnier F, Zitvogel L. Taieb J, et al. Among authors: ghiringhelli f. J Immunol. 2006 Mar 1;176(5):2722-9. doi: 10.4049/jimmunol.176.5.2722. J Immunol. 2006. PMID: 16493027
Heat shock protein 70 neutralization exerts potent antitumor effects in animal models of colon cancer and melanoma.
Schmitt E, Maingret L, Puig PE, Rerole AL, Ghiringhelli F, Hammann A, Solary E, Kroemer G, Garrido C. Schmitt E, et al. Among authors: ghiringhelli f. Cancer Res. 2006 Apr 15;66(8):4191-7. doi: 10.1158/0008-5472.CAN-05-3778. Cancer Res. 2006. PMID: 16618741
343 results
Jump to page
Feedback